White Paper Highlights how Efficacy, Safety or Quality of Final Drug Product Could be Improved Through use of Post-Cured Tubing in Biopharmaceutical Manufacturing

A white paper that provides evidence of the positive effects of post-curing on the reduction of cyclosiloxane contamination in silicone tubing manufacture has been publishedby Watson-Marlow Fluid Technology Group (WMFTG).

As a provider of single-use components including world-leading niche peristaltic pump and associated fluid path technologies, WMFTG demonstrates that the post-curing process significantly reduces the presence of cyclosiloxane contaminates in silicone tubing. Thereby, drug manufacturers opting to use post-cured tubing and tube assemblies, will benefit from improvements to the safety of the final drug product...

More From BioPortfolio on "White Paper Highlights how Efficacy, Safety or Quality of Final Drug Product Could be Improved Through use of Post-Cured Tubing in Biopharmaceutical Manufacturing"